{"name":"Clovis Oncology","permalink":"clovis-oncology","crunchbase_url":"http://www.crunchbase.com/company/clovis-oncology","homepage_url":"http://clovisoncology.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2009,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"","description":"Oncology Compound Licencing Company","created_at":"Wed Jun 17 19:11:54 UTC 2009","updated_at":"Wed Mar 14 00:38:23 UTC 2012","overview":"<p>Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. </p>","image":{"available_sizes":[[[150,39],"assets/images/resized/0017/8043/178043v1-max-150x150.png"],[[250,65],"assets/images/resized/0017/8043/178043v1-max-250x250.png"],[[262,69],"assets/images/resized/0017/8043/178043v1-max-450x450.png"]],"attribution":null},"products":[{"name":"Clovis Oncology","permalink":"clovis-oncology","image":null}],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$145M","funding_rounds":[{"round_code":"a","source_url":"http://onbiovc.com/clovis-oncology-inc-series-a-145m/","source_description":"Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development","raised_amount":145000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":26,"investments":[{"company":null,"financial_org":{"name":"Domain Associates","permalink":"domain-associates","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"New Enterprise Associates","permalink":"new-enterprise-associates","image":{"available_sizes":[[[150,110],"assets/images/resized/0001/5083/15083v3-max-150x150.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-250x250.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Aberdare Ventures","permalink":"aberdare-ventures","image":{"available_sizes":[[[150,28],"assets/images/resized/0005/3038/53038v1-max-150x150.jpg"],[[250,47],"assets/images/resized/0005/3038/53038v1-max-250x250.jpg"],[[300,57],"assets/images/resized/0005/3038/53038v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Abingworth","permalink":"abingworth-management","image":{"available_sizes":[[[150,49],"assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],[[221,73],"assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],[[221,73],"assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Frazier Healthcare Ventures","permalink":"frazier-healthcare-ventures","image":{"available_sizes":[[[150,70],"assets/images/resized/0003/2779/32779v1-max-150x150.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-250x250.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"ProQuest Investments","permalink":"proquest-investments","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],[[236,79],"assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],[[236,79],"assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/01/16/daily36-Avila-spears-4M-in-milestone-payment-from-Clovis--.html","source_description":"Avila spears $4M in milestone payment from Clovis ","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":20,"company":{"name":"Avila Therapeutics","permalink":"avila-therapeutics","image":{"available_sizes":[[[110,93],"assets/images/resized/0014/3663/143663v1-max-150x150.jpg"],[[110,93],"assets/images/resized/0014/3663/143663v1-max-250x250.jpg"],[[110,93],"assets/images/resized/0014/3663/143663v1-max-450x450.jpg"]],"attribution":null}}}}],"acquisition":null,"acquisitions":[],"offices":[{"description":"Corporate Headquarters","address1":"","address2":"","zip_code":"","city":"Boulder","state_code":"CO","country_code":"USA","latitude":40.010492,"longitude":-105.276843}],"milestones":[],"ipo":{"valuation_amount":null,"valuation_currency_code":"USD","pub_year":2011,"pub_month":11,"pub_day":16,"stock_symbol":"NASDAQ:CLVS"},"video_embeds":[],"screenshots":[],"external_links":[]}